Hypera Stock

Hypera EBITDA per Employee

The EBITDA per Employee of Hypera (HYPE3.SA) as of Aug 5, 2026 is 217,957.28 BRL. In the previous year, EBITDA per Employee was 237,113.37 BRL — a change of -8.08% (lower).

EBITDA per Employee

217,957.28BRL

YoY

-8.08%

Last updated:

EBITDA per Employee of Hypera is 2026 217,957.28 BRL. EBITDA per Employee of Hypera was 2025 237,113.37 BRL. It decreases by -8.08% lower compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

EBITDA per Employee of Hypera is 217,957.28 BRL in 2026.

EBITDA per Employee of Hypera changed from 237,113.37 BRL to 217,957.28 BRL, representing a -8.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Hypera since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Hypera historically and in real time.

Access this data via the Eulerpool API

Workforce — Hypera

All Key Metrics — Hypera